FENC

Conviction 78HealthcareScan · Thu, Jun 25, 2026

FENC$10.55+1.44%

ResistanceSupportVol 14Insider sell

Vol MA14 264.58K

Mar 26Apr 14May 1May 19Jun 8Jun 25

FENNEC PHARMACEUTICALS INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.fennecpharma.com ↗

Price10.55

Change+1.44%

Gap+0.29%

Rel volume1.32×

Avg volume317.04K

Avg $ vol3.03M

SMA 209.39

SMA 508.34

SMA 2008.06

Price vs 50+26.53%

Price vs 200+30.95%

MA stackbullish

50/200 crossgolden · 3d

Supertrendup · 8.89

RSI (14)72

MACD hist0.09

MACD crossbull · 2d

Stoch %K / %D99 / 92

ADX (14)26

+DI / −DI28 / 11

RSI divergence—

MACD divergence—

ATR %+4.96%

ADR %5.42%

52w high10.55

52w low5.77

From 52w high+0.00%

Above 52w low+82.84%

New 52w highYes

SqueezeOff

Bollinger width25.16%

%B0.99

Donchian pos98.55%

Donchian high10.58

Donchian low8.52

AVWAP (52w high)10.29

vs AVWAP high+2.50%

AVWAP (52w low)8.54

vs AVWAP low+23.55%

OBV trendUp

Chaikin MF (20)0.02

Today vs 20d1.32×

Avg vol (14d)264.58K

Avg vol (20d)317.04K

Avg $ vol (20d)3.03M

Market cap366.48M

RS 3m (vs SPY)+60.50%

RS 6m (vs SPY)+28.03%

RS line new highYes

Trend template6/8

Technical rank89.7

1 week+17.48%

1 month+6.67%

3 months+70.99%

6 months+37.19%

1 year+24.85%

YTD+37.37%

P/E-37.62

P/B9.73

P/S8.21

P/FCF-29.38

EPS-0.3400

Div yield—

ROE-25.86%

ROA-13.56%

Debt/Eq0.69

Current6.98

EV/EBITDA-56.08

Gross margin44.79%

Net margin-21.82%

Rev growth-6.09%

EPS growth-2134.17%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value352.3M

Revenue15.11M

Net income201K

Gross profit6.18M

Free cash flow-12.47M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out34.89M

Employees35

ListedMon, Jan 28, 2002

Free float26.9M

Float %78.6%

Short interest498.12K

Days to cover1.4d

Short volume34.8%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction78 / 100

Pattern quality—

Tech rank89.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.52

Support7.63

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FENC

All disclosures →

No recent disclosed trades by Congress in FENC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FENC · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Brughera Marco Maria Director · Stock Option · 2026-06-10	Grant	20K	$174K	2026-06-10	2026-06-10
Cook Jodi A Director · Stock Options · 2026-06-10	Grant	20K	$174K	2026-06-10	2026-06-10
Islam Khalid Director · Stock Option · 2026-06-10	Grant	25K	$218K	2026-06-10	2026-06-10
RALLIS CHRIS A Director · Stock Option · 2026-06-10	Grant	20K	$174K	2026-06-10	2026-06-10
Raykov Rosty Director · Common shares · 2026-06-01	Exercise	15.6K	$38K	2026-06-01	2026-06-02
Raykov Rosty Director · Common shares · 2026-06-01	Sell	9.75K	$94K	2026-06-01	2026-06-02
Raykov Rosty Director · Stock Options · 2026-06-01	Exercise	15.6K	$38K	2026-06-01	2026-06-02
Raykov Rosty Director · Common shares · 2026-05-31	Grant	2.78K	$0	2026-05-31	2026-06-02
Cioffi Christiana Marie Chief Strategy Officer · Common shares · 2026-05-31	Grant	156	$0	2026-05-31	2026-06-01
Hackman Jeffrey S. Chief Executive Officer · Common Shares · 2026-05-31	Grant	1.16K	$0	2026-05-31	2026-06-01

SEC filings

EDGAR filings in FENC · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.